Advertisement
Supplier News
Subscribe to Supplier News

The Lead

Horizon Licenses CRISPR Gene Editing Technology from Broad Institute

June 13, 2014 11:22 am | News | Comments

Horizon Discovery Group plc announced it has entered into a non-exclusive license agreement with the Broad Institute to access intellectual property related to the CRISPR/Cas9 gene editing system.  Read more...          

Horizon Discovery Acquires New Assets

May 23, 2014 1:39 pm | News | Comments

Horizon Discovery Group plc, the international life science company supplying research tools and...

AMSBIO Expands U.S. Operations

April 23, 2014 12:58 pm | News | Comments

AMSBIO has announced the opening of a new North American headquarters with executive management...

Breaking News: Cubist Recalls Cubicin Lot

April 18, 2014 2:02 pm | News | Comments

Cubist Pharmaceuticals Inc. announced it is voluntarily recalling one lot of Cubicin (daptomycin...

View Sample

FREE Email Newsletter

Daily news and top headlines for drug research professionals

Breaking News: EMA Warns of Falsified Herceptin

April 16, 2014 9:09 am | News | Comments

The EMA has been informed that vials of the cancer medicine Herceptin, thought to have been stolen in Italy, including from hospitals, have been tampered with and re-introduced under false credentials into the supply chain in some countries. Read more...

Traceable Tissue Storage Solution

April 2, 2014 4:18 pm | Product Releases | Comments

Micronic has launched a new externally threaded 3.00 ml tube that provides a fully traceable storage solution for tissue samples. Read more...

GE Healthcare Names 2013 Imaging Competition Winners

March 12, 2014 10:47 am | News | Comments

GE Healthcare Life Sciences announced Vanessa Auld, from Canada, Martin Barr, from Ireland, and Graham Wright, from Singapore, as the winners of the GE Healthcare 2013 Cell Imaging Competition. Read more...             

Advertisement

GE Healthcare Invests in FISH Technologies for Leukemia and Lymphoma Testing

March 5, 2014 9:50 am | News | Comments

GE Healthcare announced that Clarient Diagnostic Service, Inc., a GE Healthcare company, has made significant upgrades to its fluorescence in situ hybridization (FISH) technologies to improve virtual analysis of testing results for a variety of blood diseases, including leukemia, lymphoma, myelodysplastic syndrome, and myeloma.

Regulator OKs Thermo Fisher $13.6B Life Tech Deal

February 4, 2014 8:58 am | News | Comments

The Federal Trade Commission said Friday it has approved Thermo Fisher Scientific Inc.'s $13.6 billion acquisition of Life Technologies Corp., as long as the scientific instrument maker sells some assets to a unit of General Electric Co.    

Medivir AB to Use Certara’s Drug Discovery Platform

January 27, 2014 10:00 am | News | Comments

Certara announced that Medivir AB, a Swedish pharmaceutical company that focuses on infectious diseases including hepatitis C, has selected D360 as its global drug discovery platform. Read more...               

Organovo Announces Collaboration with NIH

January 14, 2014 2:04 pm | News | Comments

Organovo announced that they are joining together with two institutes from the National Institutes of Health (NIH) to help scientists develop more reliable tools for bringing safer, more effective treatments to patients on a faster timeline.    

TTP Labtech Acquires Assets in Fluorescence Lifetime Technology

January 9, 2014 10:16 am | News | Comments

Improvements in assay reagents and availability of high-throughput screen (HTS)-compatible readers has made fluorescence lifetime (FLT) technology a cost-effective screening technology. TTP Labtech has consolidated its position in the field with the purchase of assets from AssayMetrics Limited, a FLT company.

Advertisement

Thermo Fisher Scientific to Sell $1.06B in Assets to GE

January 6, 2014 10:49 am | News | Comments

Thermo Fisher Scientific announced that it has signed an agreement to sell its cell culture (sera and media), gene modulation and magnetic beads businesses to GE Healthcare, a unit of General Electric Company, for approximately $1.06 billion.    

Ready-to-Use Stable Cell Lines

January 2, 2014 10:48 am | Product Releases | Comments

AMSBIO has expanded its portfolio of stable cell lines. The new cell lines express endogenous or recombinant proteins and are available in a ready-to-use format to facilitate your research efforts. 

High-Temperature Cold/Hot Plates

December 26, 2013 9:54 am | Product Releases | Comments

Designed for laboratory research, TECA's high-temperature versions of several cold/hot plate models can heat up to +150 °C.

Evaporator for Drug Discovery

December 18, 2013 1:04 pm | Product Releases | Comments

The HT-4X centrifugal evaporator from Genevac provides sample preparation capabilities for scientists working in the drug discovery environment.

Horizon Discovery, Desktop Genetics Collaborate on CRISPR Platform

December 18, 2013 12:56 pm | News | Comments

Horizon Discovery has entered into a collaboration agreement with Desktop Genetics for development of a CRISPR design platform. The platform will be used by Horizon to quickly identify the best guide-RNAs in the human genome for each gene editing task, as part of its GENESIS suite of gene-editing technologies.

Advertisement

Semi-Automatic Microplate Sealer

December 12, 2013 2:01 pm | Product Releases | Comments

The MiniSeal II semi-automatic microplate sealer from Porvair Sciences comes complete with adapters enabling it to process deep-well, shallow-well, low-profile deep-well, filter and assay plates that conform to the ANSI/SLAS standard format. Learn more...

ImmunoChemistry Technologies Changes Ownership

December 6, 2013 11:27 am | News | Comments

ImmunoChemistry Technologies (ICT), a Minnesota-based biotechnology company that supplies unique biochemical laboratory reagents and assay tests to medical researchers, has changed ownership. Now majority women-owned, ICT develops new products to help researchers discover new treatments and drugs for cancer and other diseases affecting both animals and humans.

LiverChip Platform Tested

December 3, 2013 4:31 pm | News | Comments

Zyoxel has announced preliminary results from a testing by Sanofi on Zyoxel’s  LiverChip platform for drug metabolism and pharmacokinetic (DMPK) studies. So for what applications was the platform especially useful in the testing? Find out...

Imaging Cytometer

December 3, 2013 12:43 pm | Product Releases | Comments

Molecular Devices' next-generation SpectraMax MiniMax 300 imaging cytometer is designed to enable both cellular visualization and stain-free cell-based analysis on the field-upgradable SpectraMax i3 multi-mode microplate reader.

Custom Phospho-Specific Antibody Production Service

November 26, 2013 1:22 pm | Product Releases | Comments

AMS Biotechnology has developed a custom phospho-specific antibody production service that is design to be both reliable and to produce highly specific quality antisera. Learn more...

QIAGEN Announces Third Co-development Program for Companion Diagnostics Paired with Lilly’s Investigational Cancer Compounds

November 18, 2013 10:51 am | News | Comments

QIAGEN announced an agreement with Eli Lilly and Company to develop and commercialize a molecular companion diagnostic paired with a novel Lilly oncology compound. This is the third co-development project by QIAGEN and Lilly to create companion diagnostics, which are tests that analyze genomic information in patient samples to enable personalized decisions on treatments.

Thomson Reuters, NuMedii Launch Drug Repurposing Initiative

November 4, 2013 2:39 pm | News | Comments

The IP & Science business of Thomson Reuters and  NuMedii have started an initiative to identify new treatments for areas of unmet medical need. How does the partnership propose to systematically identify new applications for existing drug compounds? Find out...

Conjugated Secondary Antibodies

November 4, 2013 2:16 pm | Product Releases | Comments

Abcam's new Alexa Fluor 405/568/750 conjugated secondary antibodies to its existing Alexa Fluor 488/555/594/647 conjugates. Extensively tested in Abcam’s labs, the Alexa Fluor range guarantees bright staining and low background. Learn more...

Acrylamide Kits for Gel Electrophoresis

October 29, 2013 1:28 pm | Product Releases | Comments

Bio-Rad Laboratories' TGX FastCast acrylamide andTGX Stain-Free FastCast acrylamide kits are designed to provide handcast gel users access to Bio-Rad’s TGX gel chemistry, previously available only in precast gels.

Collaboration Brings Genomic Testing to Cancer Drug Developers

October 25, 2013 2:20 pm | News | Comments

Personal Genome Diagnostics Inc. will collaborate with MolecularMD to market a suite of comprehensive personalized medicine services to oncology researchers and drug developers, adding PGDx’s expertise in next-generation sequencing (NGS)-based cancer biomarker discovery to MolecularMD’s capabilities in the development, validation and global delivery of cancer companion diagnostics. Read more...

Myeloid Leukemia Cancer NGS Panel

October 24, 2013 2:38 pm | Product Releases | Comments

Integrated DNA Technologies (IDT), the world leader in oligonucleotide synthesis, is enabling cancer research with its latest next-generation sequencing (NGS) product, the xGen Acute Myeloid Leukemia Cancer Panel v1.0.

Sanofi to Use Elsevier Tools for Adverse Event Monitoring

October 22, 2013 9:29 am | News | Comments

Elsevier today announced that Sanofi has implemented QUOSA’s literature management tools to automate adverse event monitoring. QUOSA powers the retrieval, storage, tagging and annotation of relevant case reports, allowing for the creation of a centralized repository of product-related scientific literature.

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading